A group of patients in Australia are trying to change the way they get medical treatment.
They say they’re suffering from chronic pain and they need a treatment that is affordable, safe and effective.
A team of doctors and nurses have been looking into how to help them.
Their goal is to create a new medication, which they say can treat their chronic pain.
The group says there are a number of drugs on the market, including morphine, but none of them are as cheap or effective as the one the group is trying to develop.
And they say they’ve only seen about five cases of this drug being used in Australia, which makes the group hopeful the drug could be used in the future.
“We’ve seen people who are very, very, highly advanced in terms of their condition,” one of the doctors, who requested to remain anonymous, said.
“They are using this medicine and they are taking it on a regular basis.”
So if this can be used on the regular basis, then it’s a huge step forward for the community.
“The drug is being developed by Melbourne’s Institute for Clinical Medicine and Therapeutics.
The team is working with the Pharmaceutical Research and Manufacturers of Australia, a company based in Brisbane.
The drug has to be approved by the federal government before it can be prescribed in Australia.
The drugs approved in Australia to treat chronic pain are:Advil, Ativan, Tylenol, Aleve, Albuterol, Ibuprofen, and Motrin.
Drugs that can treat other conditionsA number of new drugs have been approved to treat a number or conditions, but not all are available to Australia.
Dr Chris Brown is the chief medical officer for the Institute for Primary Health Sciences.
He says they’re also looking into other medical conditions like arthritis and multiple sclerosis, but so far the only approved drug for these conditions is Albutarol.”
But there are some others that are not yet approved that we’re looking at,” Dr Brown said.
Topics:health,health-administration,medicine,medical-ethics,diseases-and-disorders,health,mental-health,pain,australiaFirst posted April 13, 2019 12:55:46Contact Greg McLeanMore stories from Australia